Yunchong Meng
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
NUAK1-Mediated Phosphorylation of NADK Mitigates ROS Accumulation to Promote Osimertinib Resistance in Non-Small Cell Lung Carcinoma.
Journal: Cancer research
Published: January 22, 2024
Promoting reactive oxygen species accumulation to overcome tyrosine kinase inhibitor resistance in cancer.
Journal: Cancer cell international
Published: September 16, 2023
USP7-mediated ERβ stabilization mitigates ROS accumulation and promotes osimertinib resistance by suppressing PRDX3 SUMOylation in non-small cell lung carcinoma.
Journal: Cancer letters
Published: September 15, 2023
Bazedoxifene-induced ROS promote mitochondrial dysfunction and enhance osimertinib sensitivity by inhibiting the p-STAT3/SOCS3 and KEAP1/NRF2 pathways in non-small cell lung cancer.
Journal: Free radical biology & medicine
Published: November 23, 2022
TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK pathway.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 28, 2021
Upregulation of estrogen receptor beta protein but not mRNA predicts poor prognosis and may be associated with enhanced translation in non-small cell lung cancer: a systematic review and meta-analysis.
Journal: Journal of thoracic disease
Published: April 14, 2021
Efficacy and safety of chimeric antigen receptor T cell immunotherapy in B-cell non-Hodgkin lymphoma: a systematic review and meta-analysis.
Journal: Immunotherapy
Published: January 07, 2021
Minimally invasive esophagectomy with intrathoracic anastomosis in a situs inversus totalis patient.
Minimally invasive esophagectomy with intrathoracic anastomosis in a situs inversus totalis patient.
Journal: Journal of surgical case reports
Published: October 07, 2020
The Prognostic Value of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma.
Journal: Frontiers in oncology
Published: September 19, 2020
Targeting YAP suppresses ovarian cancer progression through regulation of the PI3K/Akt/mTOR pathway.
Targeting YAP suppresses ovarian cancer progression through regulation of the PI3K/Akt/mTOR pathway.
Journal: Oncology reports
Published: April 24, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026